1. Home
  2. SXTP vs SHPH Comparison

SXTP vs SHPH Comparison

Compare SXTP & SHPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo 60 Degrees Pharmaceuticals Inc.

SXTP

60 Degrees Pharmaceuticals Inc.

HOLD

Current Price

$0.49

Market Cap

1.8M

Sector

Health Care

ML Signal

HOLD

Logo Shuttle Pharmaceuticals Holdings Inc.

SHPH

Shuttle Pharmaceuticals Holdings Inc.

SELL

Current Price

$4.90

Market Cap

2.1M

Sector

Health Care

ML Signal

SELL

Company Overview

Basic Information
Metric
SXTP
SHPH
Founded
2010
2012
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.8M
2.1M
IPO Year
2023
2022

Fundamental Metrics

Financial Performance
Metric
SXTP
SHPH
Price
$0.49
$4.90
Analyst Decision
Buy
Analyst Count
2
0
Target Price
★ $3.70
N/A
AVG Volume (30 Days)
★ 321.8K
25.9K
Earning Date
11-27-2026
11-27-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 36.77
N/A
EPS
★ N/A
N/A
Revenue
★ $1,005,471.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$70.00
N/A
P/E Ratio
N/A
★ N/A
Revenue Growth
★ 65.49
N/A
52 Week Low
$0.34
$0.38
52 Week High
$8.62
$8.88

Technical Indicators

Market Signals
Indicator
SXTP
SHPH
Relative Strength Index (RSI) 29.77 41.02
Support Level N/A $2.83
Resistance Level $1.01 $4.81
Average True Range (ATR) 0.11 0.43
MACD -0.03 -0.11
Stochastic Oscillator 6.02 15.83

Price Performance

Historical Comparison
SXTP
SHPH

About SXTP 60 Degrees Pharmaceuticals Inc.

60 Degrees Pharmaceuticals Inc operates as a specialty pharmaceutical company with the goal of using biological science and applied research to develop and commercialize new therapies for the prevention and treatment of infectious diseases. Currently, company's pipeline under development covers development programs for vector-borne, fungal, and viral diseases utilizing three of the Company's future products: (i) new products that contain the Arakoda regimen of Tafenoquine; (ii) new products that contain Tafenoquine; and (iii) Celgosivir and/or botanical extracts from Australian Chestnut Trees.

About SHPH Shuttle Pharmaceuticals Holdings Inc.

Shuttle Pharmaceuticals Holdings Inc is a clinical-stage pharmaceutical company leveraging its proprietary technology to develop novel therapies designed to cure cancers. The company has one operating segment with a focus on the development of novel drug therapies, including cancer therapies, extending new applications of radiation therapy, and other drug development, including through the use of the Molecule.ai platform by the company as well as licensing the right to use Molecuile.ai to others. The company's goal is to extend the benefits of cancer treatments with surgery, radiation therapy, chemotherapy and immunotherapy. Radiation therapy (RT) is one of the effective modalities for treating cancers. Its pipeline includes: Ropidoxuridine, HDAC Inhibitors, PSMA-B, and PC-Rad Test.

Share on Social Networks: